Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3129198rdf:typepubmed:Citationlld:pubmed
pubmed-article:3129198lifeskim:mentionsumls-concept:C0027950lld:lifeskim
pubmed-article:3129198lifeskim:mentionsumls-concept:C2003888lld:lifeskim
pubmed-article:3129198lifeskim:mentionsumls-concept:C0521449lld:lifeskim
pubmed-article:3129198lifeskim:mentionsumls-concept:C0023946lld:lifeskim
pubmed-article:3129198lifeskim:mentionsumls-concept:C0201925lld:lifeskim
pubmed-article:3129198lifeskim:mentionsumls-concept:C1272755lld:lifeskim
pubmed-article:3129198pubmed:issue2lld:pubmed
pubmed-article:3129198pubmed:dateCreated1988-5-31lld:pubmed
pubmed-article:3129198pubmed:abstractTextChemotactic factors stimulate the rate of locomotion of polymorphonuclear leukocytes (PMNs). To investigate the importance of cytoplasmic calcium we have examined the ability of the chemotactic peptide N-formylnorleucyl eucylphenalanine (FNLLP) to stimulate the locomotion of PMNs whose cytoplasmic calcium levels were reduced by incubation in EGTA or in EGTA plus the calcium ionophores, ionomycin or A23187. Locomotion was assayed by migration through micropore filters and by time-lapse videomicroscopy. Cells in EGTA exhibited similar or slightly reduced rates of locomotion compared to cells in Hanks' balanced salt solution (HBSS). The peptide dose dependence for the stimulation of locomotion was similar in medium containing calcium or EGTA. The presence of 1 microM ionophore plus EGTA had no effect on the stimulation of locomotion by peptide. The presence of ionophores (1 microM) plus external calcium inhibited locomotion.lld:pubmed
pubmed-article:3129198pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3129198pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3129198pubmed:languageenglld:pubmed
pubmed-article:3129198pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3129198pubmed:citationSubsetIMlld:pubmed
pubmed-article:3129198pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3129198pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3129198pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3129198pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3129198pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3129198pubmed:statusMEDLINElld:pubmed
pubmed-article:3129198pubmed:issn0886-1544lld:pubmed
pubmed-article:3129198pubmed:authorpubmed-author:CarsonMMlld:pubmed
pubmed-article:3129198pubmed:authorpubmed-author:ZigmondS HSHlld:pubmed
pubmed-article:3129198pubmed:authorpubmed-author:SlonczewskiJ...lld:pubmed
pubmed-article:3129198pubmed:authorpubmed-author:WildeM WMWlld:pubmed
pubmed-article:3129198pubmed:issnTypePrintlld:pubmed
pubmed-article:3129198pubmed:volume9lld:pubmed
pubmed-article:3129198pubmed:ownerNLMlld:pubmed
pubmed-article:3129198pubmed:authorsCompleteYlld:pubmed
pubmed-article:3129198pubmed:pagination184-9lld:pubmed
pubmed-article:3129198pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:3129198pubmed:meshHeadingpubmed-meshheading:3129198-...lld:pubmed
pubmed-article:3129198pubmed:meshHeadingpubmed-meshheading:3129198-...lld:pubmed
pubmed-article:3129198pubmed:meshHeadingpubmed-meshheading:3129198-...lld:pubmed
pubmed-article:3129198pubmed:meshHeadingpubmed-meshheading:3129198-...lld:pubmed
pubmed-article:3129198pubmed:meshHeadingpubmed-meshheading:3129198-...lld:pubmed
pubmed-article:3129198pubmed:meshHeadingpubmed-meshheading:3129198-...lld:pubmed
pubmed-article:3129198pubmed:meshHeadingpubmed-meshheading:3129198-...lld:pubmed
pubmed-article:3129198pubmed:meshHeadingpubmed-meshheading:3129198-...lld:pubmed
pubmed-article:3129198pubmed:meshHeadingpubmed-meshheading:3129198-...lld:pubmed
pubmed-article:3129198pubmed:meshHeadingpubmed-meshheading:3129198-...lld:pubmed
pubmed-article:3129198pubmed:meshHeadingpubmed-meshheading:3129198-...lld:pubmed
pubmed-article:3129198pubmed:year1988lld:pubmed
pubmed-article:3129198pubmed:articleTitlePolymorphonuclear leukocyte locomotion is insensitive to lowered cytoplasmic calcium levels.lld:pubmed
pubmed-article:3129198pubmed:affiliationBiology Department, University of Pennsylvania, Philadelphia.lld:pubmed
pubmed-article:3129198pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3129198pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:3129198pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3129198lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3129198lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3129198lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3129198lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3129198lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3129198lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3129198lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3129198lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3129198lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3129198lld:pubmed